Page last updated: 2024-11-05

vesnarinone and Mouth Neoplasms

vesnarinone has been researched along with Mouth Neoplasms in 3 studies

Mouth Neoplasms: Tumors or cancer of the MOUTH.

Research Excerpts

ExcerptRelevanceReference
"Vesnarinone is a synthesized positive oral inotropic agent that has multiple biological activities on mammalian cells both in vitro and in vivo."1.33Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8. ( Harada, K; Sato, M; Yoshida, H, 2005)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Uchida, D1
Onoue, T1
Begum, NM1
Kuribayashi, N1
Tomizuka, Y1
Tamatani, T1
Nagai, H1
Miyamoto, Y1
Harada, K1
Yoshida, H1
Sato, M1
Yoneda, K1
Yamamoto, T1
Ueta, E1
Osaki, T1

Other Studies

3 other studies available for vesnarinone and Mouth Neoplasms

ArticleYear
Vesnarinone downregulates CXCR4 expression via upregulation of Krüppel-like factor 2 in oral cancer cells.
    Molecular cancer, 2009, Aug-12, Volume: 8

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cisplatin; Down-Regulation; Flow Cy

2009
Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
    International journal of oncology, 2005, Volume: 27, Issue:6

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell

2005
Induction of cyclin-dependent kinase inhibitor p21 in vesnarinone-induced differentiation of squamous cell carcinoma cells.
    Cancer letters, 1998, Nov-13, Volume: 133, Issue:1

    Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Differentiation; Cyclin E; Cyclin-Dependent Kinase Inhibit

1998